Gynecologic cancers and non-coding RNAs: epigenetic regulators with emerging roles

ZS Razavi, V Tajiknia, S Majidi, M Ghandali… - Critical reviews in …, 2021 - Elsevier
Gynecologic cancers involve the female genital organs, such as the vulva, vagina, cervix,
endometrium, ovaries, and fallopian tubes. The occurrence and frequency of gynecologic …

MicroRNAs and their influence on the ZEB family: mechanistic aspects and therapeutic applications in cancer therapy

M Ashrafizadeh, HL Ang, ER Moghadam… - Biomolecules, 2020 - mdpi.com
Molecular signaling pathways involved in cancer have been intensively studied due to their
crucial role in cancer cell growth and dissemination. Among them, zinc finger E-box binding …

PDHB-AS suppresses cervical cancer progression and cisplatin resistance via inhibition on Wnt/β-catenin pathway

C Chi, W Hou, Y Zhang, J Chen, Z Shen, Y Chen… - Cell Death & …, 2023 - nature.com
Cervical cancer (CC) is the most prevalent gynecological malignancy occurring in the cervix.
Long non-coding RNAs (lncRNAs) can act as oncogenes or anti-oncogenes in CC …

Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA

T Mitra, S Elangovan - Molecular and Cellular Biochemistry, 2021 - Springer
Cervical cancer (CC) is one of the leading causes of death in women due to cancer and a
major concern in the developing world. Persistent human papilloma virus (HPV) infection is …

Long noncoding RNA H19 acts as a miR‐340‐3p sponge to promote epithelial‐mesenchymal transition by regulating YWHAZ expression in paclitaxel‐resistant breast …

L Yan, S Yang, CX Yue, XY Wei, W Peng… - Environmental …, 2020 - Wiley Online Library
Breast cancer (BC) is the leading cause of cancer‐related death in women worldwide and
one of the most prevalent malignancy. In recent years, increasing evidence had illuminated …

ceRNA networks in gynecological cancers progression and resistance

S Wu, B Zhong, Y Yang, Y Wang… - Journal of Drug Targeting, 2023 - Taylor & Francis
Gynecological cancers are the second most common types of cancer in women. Clinical
diagnosis of these cancers is often delayed or misdiagnosed due to lack of insight into their …

[HTML][HTML] IncRNA MAPKAPK5-AS1 promotes proliferation and migration of thyroid cancer cell lines by targeting miR-519e-5p/YWHAH

Y Zhou, S Liu, Y Luo, M Zhang, X Jiang… - European journal of …, 2020 - ncbi.nlm.nih.gov
Thyroid cancer is a common malignant tumour of the endocrine system and ranks ninth in
cancer incidence worldwide. An extensive body of evidence has demonstrated that lncRNAs …

lncRNA RPPH1 promotes non‑small cell lung cancer progression through the miR‑326/WNT2B axis

Y Wu, K Cheng, W Liang, X Wang - Oncology Letters, 2020 - spandidos-publications.com
Long non‑coding RNAs (lncRNAs) serve important regulatory roles in human tumors. The
aim of the present study was to examine the role of ribonuclease P RNA component H1 …

[HTML][HTML] Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in …

W Liu, R Zhuang, S Feng, X Bai, Z Jia, E Kapora… - Biomedicine & …, 2020 - Elsevier
Background Cervical cancer (CC) is one of the most common cancers in women. Long non-
coding RNAs (lncRNAs) have been proposed as therapeutic targets in CC. Hence, the …

HANR enhances autophagy-associated sorafenib resistance through miR-29b/ATG9A axis in hepatocellular carcinoma

Y Shi, X Yang, X Xue, D Sun, P Cai, Q Song… - OncoTargets and …, 2020 - Taylor & Francis
Background Hepatocellular carcinoma (HCC) is one of the most common malignancies
worldwide and chemoresistance is the main obstacle for effective treatments of HCC …